AzTrials
AzTrials

ObesityNCT03297931

Comparison of Pulse Chips and Commercial Snacks on Food Intake, Appetite and Blood Glucose in Healthy Young Adults

A study testing Corn Chips + Onion Dip, Yellow pea chip + hummus and Pinto bean chip + hummus in people with Obesity and Diabetes, run by University of Toronto at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Consumers are often forced to eat fast, convenient foods and snacks ("eat on the go") in order to match the pace of their lifestyles. However, these snack options more often than not offer little health benefit to the consumer. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Obesity, Diabetes
What is being tested?
Corn Chips + Onion Dip, Yellow pea chip + hummus and Pinto bean chip + hummus
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteCanada
Study dates
19 Jul 2017to 31 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age: ≥18 and ≤45 years
  • BMI: ≥ 18.5 and ≤ 29.9 kg/m2
  • Fasting serum glucose: ≤ 5.6 mmol/L
  • Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
  • Willing to maintain current dietary supplement use throughout the trial. On test days, subject agrees not to take any dietary supplements until dismissal from the Department of Nutritional Sciences. Failure to comply will result in a rescheduled test visit.
  • Willing to abstain from alcohol consumption for 24 h prior to all test visits.
  • Willing to avoid vigorous physical activity for 24 h prior to all test visits.
  • Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

Who cannot join

  • Fasting blood glucose > 5.6 mmol/L
  • Smoking
  • Thyroid problems
  • Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorptive syndrome, pancreatitis, gallbladder or biliary disease.
  • Presence of gastrointestinal disorder or surgeries within the past year.
  • Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgement.
Show all 15Show fewer
  • Patients who have undergone bariatric surgery at any point.
  • Known to be pregnant or lactating.
  • Unwillingness or inability to comply with the experimental procedures
  • Known intolerance, sensitivity or allergy to pulses or dairy.
  • Extreme dietary habits (ie. Atkins diet, very high protein diets, etc.).
  • Uncontrolled hypertension (systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg) as defined by the average blood pressure measured at screening.
  • Weight gain or loss of at least 10 lbs in previous three months.
  • Excessive alcohol intake (more than 2 drinks per day or more than 9 drinks per week)
  • Restrained Eaters

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Toronto

    Toronto, Ontario, M5S 3E2

Other trials in Canada

About this study

Official title: Comparison of Roasted Pulse Snacks, Pulse Chips and Commercial Snacks on Post-prandial Food Intake, Appetite and Glycemic Response in Healthy Young Adults

Consumers are often forced to eat fast, convenient foods and snacks ("eat on the go") in order to match the pace of their lifestyles. However, these snack options more often than not offer little health benefit to the consumer. In fact, 55% of calories consumed by Canadians are ultra processed foods, which are limited in their nutrient profile and only offer empty calories. Subsequently, these foods lead the consumer to eat more and provides little to no feelings of satiety or satiation. the proposed objectives of the current project are to examine the physiological benefit(s) of consuming readily available pulse snacks and compare them to other commonly consumed snack varieties. This work aims to incentivize consumers to seek out pulses as valuable snacking options and highlight the benefit of including these as alternatives to other energy-dense snacks that lack the nutritional composition of pulses.

Read the detailed description

Hypothesis of the study: Inclusion of pulses as part of a snack will lower appetite and post-prandial glycemia (PPG) in comparison to commercial, commonly consumed non-pulse snacks.

Overall Objective of the study: To investigate and compare the effects of pulse and non-pulse snacks served as chips and dip on appetite and PPG in healthy adults.

Specific objectives of the study: To test the acute effects of different pulse snacks on: 1) PPG and appetite for three hours, and 2) food intake 1 hour following consumption of snacks.

Conditions
Obesity, Diabetes
Being tested
Corn Chips + Onion Dip, Yellow pea chip + hummus, Pinto bean chip + hummus, Pinto bean chip + onion dip, Yellow pea chip + onion dip
Keywords
Pulse, Snack, Post-prandial glycemia, Appetite, Food intake, Young adults, Satiety
Medical subject headings
Obesity, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Corn Chips + Onion DipDietary supplement

    Non-pulse chip + non-pulse dip

  • Yellow pea chip + hummusDietary supplement

    Novel pulse chip + pulse spread

  • Pinto bean chip + hummusDietary supplement

    Commercial pulse chip + pulse spread

  • Pinto bean chip + onion dipDietary supplement

    Commercial pulse chip + non-pulse spread

  • Yellow pea chip + onion dipDietary supplement

    Novel pulse chip + non-pulse spread

  • Corn chips + hummusDietary supplement

    Non-pulse chip + pulse spread

Study groups in NCT03297931
Study groupRoleWhat they receive
Commercial corn chips + Onion dipActive comparatorCorn chips + onion dip
Receives: Dietary Supplement: Corn Chips + Onion Dip
Commercial pulse chip + pulse spreadExperimentalPinto bean chip + hummus
Receives: Dietary Supplement: Pinto bean chip + hummus
Novel pulse chip + pulse spreadExperimentalYellow pea chip + hummus
Receives: Dietary Supplement: Yellow pea chip + hummus
Commercial pulse chip + non-pulse spreadExperimentalPinto bean chip + onion dip
Receives: Dietary Supplement: Pinto bean chip + onion dip
Novel pulse chip + non-pulse spreadExperimentalYellow pea chip + onion dip
Receives: Dietary Supplement: Yellow pea chip + onion dip
Non-pulse chip + pulse spreadExperimentalCorn chips + hummus
Receives: Dietary Supplement: Corn chips + hummus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in blood glucose levels

    Each participant will attend 6 sessions in total (randomized 6-arm cross-over design)

    Measured: Starting at the beginning of each session (0 minutes, before consumption of treatment) and every 15 - 30 minutes up to 190 minutes (time of completion of each session)

  2. Subjective appetite

    Measured using Visual Analog Scales (VAS)

    Measured: Measured every 15-30 minutes up to 190 minutes

  3. Food intake

    Food intake is measured by the amount of pizza (in grams) consumed during the 20 minute period (pizza is served ad libitum)

    Measured: 65 minutes after completion of treatment, 20 minutes is allocated to allow for pizza consumption

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2017
  2. Study start19 Jul 2017
  3. Primary completion31 Dec 2023
  4. Study completion31 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03297931
Sponsor's protocol ID
SPG_Snack Study
Status last verified
Mar 2025
First submitted
25 Sep 2017
Last updated
28 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Corn Chips + Onion Dip, Yellow pea chip + hummus and Pinto bean chip + hummus in people with Obesity and Diabetes, run by University of Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in blood glucose levels (time frame: Starting at the beginning of each session (0 minutes, before consumption of treatment) and every 15 - 30 minutes up to 190 minutes (time of completion of each session)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in